Project Grant HT9425261E099
Award Date 5/1/26
Completion Date 4/30/29
Dollars Obligated $700K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
University City, MO 63130, USA
Similar Awards
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $894,125 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) to support research titled "Understanding and Targeting Epigenetic Vulnerabilities in NF-1-MPNST." The three-year award, effective from July 15, 2025 through July 14, 2028, funds advanced biomedical research investigating epigenetic mechanisms and...
- Federal Grant Award Summary The Washington University was awarded $500,000 in Project Grant funding from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2027. The award supports research titled "Harnessing Single-Cell T Cell-Receptor Sequencing to Accelerate Diagnosis in Inflammatory Arthritis," to be conducted at the university's University City, Missouri campus. This research project...
- Federal Grant Award Summary The Washington University received a $155,500 project grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025, through September 30, 2027. The research project investigates LAT1 (L-type amino acid transporter 1) as a therapeutic and diagnostic marker in malignant peripheral nerve sheath tumors (MPNSTs). This two-year initiative supports hypothesis-driven biomedical research...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $256,208 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The grant supports research on deuterium metabolic imaging as a noninvasive diagnostic tool to measure metabolic reprogramming in glioblastoma, a severe form of brain cancer. This research aims to develop...
- Federal Project Grant Award Summary Columbia University's Health Sciences Division received a $750,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) with a performance period from July 1, 2026 through June 30, 2029. The award funds research to identify novel therapeutic targets that overcome treatment resistance in triple-negative breast cancer (TNBC), a particularly aggressive form of cancer with limited...
- Federal Project Grant Award Summary The Washington University received a $210,292 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025 through July 31, 2027. The award supports research into "Deuterium Metabolic Imaging to Noninvasively Measure Metabolic Reprogramming in Glioblastoma," conducted at the university's Office of Sponsored Research Services in University City, Missouri....
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $834,915 project grant under the Military Medical Research and Development program (CFDA 12.420) for the period May 1, 2026 through April 30, 2028. The project, titled "Development of Small Molecules to Disrupt TDP-43 Aggregation and Restore Function," will be conducted at the university's facilities in University City, Missouri. This award funds research and development activities...
- Federal Grant Award Summary The University of Washington received a $1,494,943 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026 through March 31, 2029. The award supports research and development services focused on biomaterial strategies to improve the specificity and efficacy of Chimeric Antigen Receptor (CAR) T cell therapy for breast cancer treatment. This research initiative aligns...
- Federal Grant Award Summary The Washington University's Office of Sponsored Research Services received a $447,625 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective June 1, 2025, through May 31, 2028. This award supports research on refractive surgery for autism spectrum disorder (ASD), leveraging the university's established capabilities in advanced biomedical research and clinical investigation. The...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded The Washington University a $4,876,076 Project Grant on August 1, 2025, under the Military Medical Research and Development program (CFDA 12.420) to develop a novel point-of-care (POC) multiplex device for classifying molecular phenotypes of acute respiratory distress syndrome and sepsis. The four-year award, extending through July 31, 2029, supports research and development of an innovative diagnostic technology...